Novartis AG vs Prologis Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Prologis Inc trades at $151.05 (market cap $137.50B). The key difference: Novartis AG is far larger — about 2.1× Prologis Inc's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | PLD | |
|---|---|---|
Market Cap | $290.25B | $137.50B |
Sector | Health | Real Estate |
52-Week High | $168.62 | $149.96 |
52-Week Low | $113.50 | $104.08 |
Enterprise Value | $330.27B | $172.18B |
Dividend Yield | 3.17% | 2.9% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →